Henkel cosmetics sales
This article was originally published in The Rose Sheet
Executive SummaryWorldwide cosmetics/toiletries sales up 2.8% to $1.84 bil. (€1=$.87) in 2001, Henkel announces March 5. Cosmetics group reported strong fourth quarter due to price increases intended to pre-empt the effect of the Euro change, shifts to higher-margin products, firm explains. Operating profits for the unit rose 12% to $145.4 mil. In the U.S., firm will sell the manufacturing plant formerly used for Dep and L.A. Looks and has moved to contract production for the brands. Future plans include hair care product launches, search for "appropriate" acquisitions, Henkel says...
You may also be interested in...
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.
Two late-stage trials of Austedo have missed their endpoints in the neurological disorder, meaning Teva will miss out on an additional revenue stream from the VMAT2 inhibitor.